113 related articles for article (PubMed ID: 11057878)
1. The C536T transition in the tissue factor pathway inhibitor (TFPI) gene does not contribute to risk of venous thrombosis among carriers of factor V Leiden.
Hessner MJ; Luhm RA
Thromb Haemost; 2000 Oct; 84(4):724-5. PubMed ID: 11057878
[No Abstract] [Full Text] [Related]
2. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
[TBL] [Abstract][Full Text] [Related]
3. The 536C-->T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis.
Kleesiek K; Schmidt M; Götting C; Schwenz B; Lange S; Müller-Berghaus G; Brinkmann T; Prohaska W
Thromb Haemost; 1999 Jul; 82(1):1-5. PubMed ID: 10456444
[TBL] [Abstract][Full Text] [Related]
4. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
5. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
van Dunné FM; Doggen CJ; Heemskerk M; Rosendaal FR; Helmerhorst FM
Hum Reprod; 2005 Mar; 20(3):802-6. PubMed ID: 15618258
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
8. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
[TBL] [Abstract][Full Text] [Related]
9. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
10. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.
Ameziane N; Seguin C; Borgel D; Fumeron F; Moatti D; Alhenc-Gelas M; Grandchamp B; Aiach M; Emmerich J; de Prost D
Thromb Haemost; 2002 Aug; 88(2):195-9. PubMed ID: 12195688
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of the C536T mutation in the tissue factor pathway inhibitor (TFPI) gene among patients with venous thromboembolic disease.
Paciaroni K; Rossi E; Bazzan M; Ireland H; De Stefano V
Thromb Haemost; 2001 May; 85(5):938-9. PubMed ID: 11372693
[No Abstract] [Full Text] [Related]
12. Mesenteric vein thrombosis in a pregnant patient heterozygous for the factor V (1691 G --> A) Leiden mutation.
Sönmezer M; Aytaç R; Demirel LC; Kurtay G
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):234-5. PubMed ID: 15140521
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
14. ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden.
Robert A; Aillaud MF; Eschwège V; Randrianjohany A; Scarabin Y; Juhan-Vague I
Thromb Haemost; 2000 Apr; 83(4):630-1. PubMed ID: 10780330
[No Abstract] [Full Text] [Related]
15. [Cerebral venous thrombosis and factor V Leiden mutation].
Meng Q; Pu C
Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):47-9. PubMed ID: 11953127
[TBL] [Abstract][Full Text] [Related]
16. An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested case-control study.
Hiltunen L; Rautanen A; Rasi V; Kaaja R; Kere J; Krusius T; Vahtera E; Paunio M
Thromb Res; 2007; 119(4):423-32. PubMed ID: 16765424
[TBL] [Abstract][Full Text] [Related]
17. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
18. Prolonged seated immobility-associated venous coagulability in a factor V Leiden heterozygote: a case-comparative study.
Ansari MT; Cheung BM; Karlberg JP
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):187-91. PubMed ID: 16575256
[TBL] [Abstract][Full Text] [Related]
19. [Combination of heterozygote blood coagulation factor V Leiden carriage with erythrocytosis as a cause of the hip deep vein thrombosis].
Idelson LI; Albert II; Rudensky B; Levy-Lahad E; Renbaum P; Klein G
Ter Arkh; 2002; 74(2):66-70. PubMed ID: 11899832
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
